PUBLISHER: The Insight Partners | PRODUCT CODE: 2165888
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165888
The Europe Automated Peritoneal Dialysis Market is projected to grow from US$ 263.6 Million in 2025 to US$ 374.0 Million by 2034. The market is anticipated to register a CAGR of 4.0% during the forecast period from 2026 to 2034.
Executive Summary and Europe Automated Peritoneal Dialysis Market Analysis
The Europe automated peritoneal dialysis market is witnessing consistent expansion, driven by the growing prevalence of chronic kidney disease (CKD), increasing requirements for kidney replacement therapy (KRT), and the broader transition toward home-based healthcare. According to the European Renal Association 2023 Annual Registry Report, KRT prevalence reached approximately 1,101 patients per million population in 2023, representing a substantial patient population requiring dialysis or kidney transplantation. The expanding number of patients requiring renal replacement treatment is consequently supporting demand for flexible modalities such as automated peritoneal dialysis.
The same registry indicates that peritoneal dialysis represented nearly 11% of incident dialysis patients in 2023, demonstrating continued interest in home-based treatment options. Healthcare systems throughout Europe are increasingly emphasizing decentralized, patient-focused treatment models that support greater independence while reducing pressure on hospitals and dialysis centers. This shift is encouraging the adoption of automated dialysis technologies that enable patients to manage treatment more conveniently at home.
Technological progress is also strengthening APD adoption. Modern cyclers equipped with remote monitoring capabilities, enhanced safety functions, and improved treatment management features are helping increase patient adherence and clinical outcomes. Together with supportive European healthcare policies and growing recognition of the benefits associated with home dialysis, these developments are expected to sustain growth in the Automated Peritoneal Dialysis Market across Europe.
Strategic Insights
Europe Automated Peritoneal Dialysis Market Segmentation Analysis
By Product Type, the Europe Automated Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment dominated the market in 2025.
By End User, the Europe Automated Peritoneal Dialysis Market is categorized into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment held the dominant position in 2025.
Market Report Scope
Europe Automated Peritoneal Dialysis Market Outlook
Technological advancements in automated dialysis equipment and related solutions remain a major factor supporting the expansion of the Automated Peritoneal Dialysis Market. During 2023-2025, manufacturers continued to develop and improve APD cyclers with features such as enhanced ease of use, stronger connectivity, remote monitoring, intelligent alarm systems, and more sophisticated fluid management algorithms. These improvements have made APD systems increasingly suitable for home use, including among patients with limited previous experience with dialysis equipment.
Such innovations are particularly important because APD generally depends on automated cycler systems to perform overnight fluid exchanges, distinguishing it from continuous ambulatory peritoneal dialysis (CAPD). Automated overnight treatment can improve convenience, support adherence, and assist with fluid management while allowing patients to maintain greater independence in their daily routines.
Remote treatment monitoring and smartphone-connected cyclers enable healthcare professionals to supervise therapy without requiring patients to make frequent visits to dialysis centers. This combination of digital connectivity and patient autonomy is increasing the attractiveness of APD among healthcare providers and payers. In addition, improved infection-control technologies and advanced safety features are helping address important clinical concerns associated with peritoneal dialysis, supporting greater confidence when prescribing APD to patients with complex health profiles or multiple comorbidities.
These technological developments are strengthening clinician preference for APD in developed healthcare markets such as Europe and North America, where digital health technologies are becoming increasingly integrated into the management of chronic diseases.
Europe Automated Peritoneal Dialysis Market Country Insights
By country, the Europe Automated Peritoneal Dialysis Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The Rest of Europe segment accounted for the largest market share in 2025.
Countries including the Netherlands, Russia, Switzerland, Poland, Belgium, Sweden, Ireland, and Norway are among the major contributors to the automated peritoneal dialysis market within the Rest of Europe. Market growth across these countries is supported by the increasing prevalence of kidney disease, established renal patient registries, and growing adoption of home-based dialysis therapies.
According to European Renal Association Registry 2023-2024 country-level data, peritoneal dialysis utilization in the Netherlands reached approximately 18-20% among dialysis patients, representing one of the higher adoption rates in Europe and reflecting the country's established home dialysis infrastructure. Sweden and Norway have also recorded relatively strong adoption, with peritoneal dialysis accounting for approximately 20-25% of prevalent dialysis modalities, supported by well-developed home healthcare systems.
Ireland is continuing to develop its home dialysis programs, with national healthcare strategies placing greater emphasis on expanding access to peritoneal dialysis. In Poland, national nephrology data reported through the ERA in 2023 indicates that peritoneal dialysis accounted for approximately 10% of dialysis treatments, with adoption gradually increasing alongside healthcare system modernization.
Switzerland and Belgium demonstrate moderate but relatively stable use of peritoneal dialysis, with PD representing single-digit to low double-digit shares of their overall dialysis populations. Meanwhile, Russia is continuing to develop its dialysis infrastructure, with peritoneal dialysis receiving increasing attention within national renal care programs. These country-level developments collectively contribute to the expansion of the automated peritoneal dialysis market throughout the Rest of Europe.
Europe Automated Peritoneal Dialysis Market Company Profiles
Key companies participating in the Europe Automated Peritoneal Dialysis Market include Terumo Corp, Medtronic Plc, Asahi Kasei Corp, Baxter International Inc, Fresenius Medical Care AG & Co KGaA, B. Braun SE, Angiplast, Becton Dickinson and Co, Utah Medical Products Inc, and Poly Medicure Ltd.
These market participants are implementing strategies such as geographic expansion, product innovation, strategic business development, and mergers and acquisitions. Through these initiatives, companies aim to strengthen their product portfolios, introduce advanced dialysis technologies, meet changing patient and healthcare-provider requirements, and expand their market share within the automated peritoneal dialysis industry.